Journal List > Allergy Asthma Respir Dis > v.4(3) > 1059178

Mun, Kim, Kim, Park, Kim, Shin, and Son: A study of the use of home mechanical ventilator and medical insurance

Abstract

Purpose

Use of a home mechanical ventilator can shorten the hospitalization duration of children with chronic respiratory failure requiring longterm use of a mechanical ventilator. In this study, the researchers analyzed patients who had used a home mechanical ventilator.

Methods

From January 2009 to July 2014, we retrospectively investigated 15 patients under 18 years of age, from 2 hospitals, and their use of home mechanical ventilators.

Results

The median age of the patients was 55 months. Ten children were male, and 5 were female. As for the type of mechanical ventilators, 10 used a pressure type, 3 used a volume type, and 2 used a volume-mask type. Analysis of underlying diseases revealed that 10 children had neuromuscular disease, 3 had pulmonary disease, and 2 suffered from hypoxic ischemic encephalopathy. The number of patients who were discharged from the hospital with a home mechanical ventilator was 13. One child died of sepsis irrespective of the mechanical ventilator. Six patients had health insurance. But 9 did not. The group with insurance had the possibility of being discharged earlier than the group without. On readmission, the length of hospitalization was also reduced in patients who had used a home mechanical ventilator.

Conclusion

Use of a mechanical ventilator at home is helpful in patients who need longterm use of a mechanical ventilator due to neuromuscular disease, chronic pulmonary diseases, and accidents because complications are rare and insurance coverage is feasible.(Allergy Asthma Respir Dis 2016;4:195–198)

References

1. Suh J, Lee JH, Chung MK, Jeong HS, Son YI, Ahn K, et al. Causes and outcome of tracheostomy in children. Pediatr Allergy Respir Dis. 2012; 22:188–96.
crossref
2. King AC. longterm home mechanical ventilation in the United States. Respir Care. 2012; 57:921–30.
crossref
3. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990; 142:523–8.
crossref
4. Ahn YJ, Lee SH, Kim HB, Park SJ, Ko TS, Hong SJ. Clinical study of children using home mechanical ventilation. Korean J Pediatr. 2005; 48:401–5.
5. Kim KO, Oh AY, Lee CJ, Park CD, Kim CS. Home mechanical ventilation of pediatric patients. Korean J Anesthesiol. 2003; 44:229–34.
crossref
6. Cancelinha C, Madureira N, Macao P, Pleno P, Silva T, Estevao MH, et al. longterm ventilation in children: ten years later. Rev Port Pneumol (2006). 2015; 21:16–21.
crossref
7. Kim MH, Kim HS, Park JD. Factors Influencing Readmission of Home Ventilator-Assisted Children. J Korean Acad Child Health Nurs. 2012; 18:9–18.
crossref
8. Han YJ, Park JD, Lee B, Choi YH, Suh DI, Lim BC, et al. Home mechanical ventilation in childhood-onset hereditary neuromuscular diseases: 13 years' experience at a single center in Korea. PLoS One. 2015; 10:e0122346.
crossref
9. Amin RS, Fitton CM. Tracheostomy and home ventilation in children. Semin Neonatol. 2003; 8:127–35.
crossref

Table 1.
Demographic characteristics of the patients applying home mechanical ventilator (n=15)
Characteristic Value
Male sex 10 (66.7)
Age of applying home mechanical ventilator (yr), median (IQR) 4.6 (1.2–14.0)
Tracheostomy 13 (86.7)
Mode of ventilator  
Pressure control–SIMV with tracheostomy 10 (66.7)
Volume control–SIMV with tracheostomy 3 (20.0)
Volume mask type without tracheostomy 2 (31.2)
Weaning from ventilator 2 (13.3)
Expired 1 (6.7)
Follow-up period from applying home ventilator (yr), mean (IQR) 2.2 (0.7–2.4)

Values are presented as number of patients (%) unless otherwise indicated. IQR, interquartile range; SIMV, synchronized intermittent mandatory ventilation.

Table 2.
Underlying disease of patients (n=15)
Disease No. of patients (%) Application of insurance
Neuromuscular disease 10 (66.7)  
Muscular dystrophy 4 (26.7) Y
Mitochondrial disease 3 (20.0) Y
Spinal muscular dystrophy 2 (13.3) Y
Metachromatic leukodystrophy 1 (6.7) N
Respiratory disease 3 (20.0)  
Chronic lung disease 2 (13.3) N
Asphyxating thoracic dysplasia 1 (6.7) N
HIE 2 (13.3) N

HIE, hypoxic ischemic encephalopathy.

Table 3.
Duration from tracheostomy to applying home mechanical ventilator according to insurance (n=13)
Group Duration (day), median (range) P-value
Insurance group (n=7) 30 (3–67) 0.035
Noninsurance group (n=6) 127 (23–868)  

Mann-Whitney test.

Table 4.
Duration of hospitalization depending on applying home mechanical ventilator
Group Home ventilato apply (day) P-value
Before After
Insurance group 113.6±155.7 11.2±21.7 0.008
Non insurance group 85.9±102.2 21.2±21.0 0.075
Total 102.5±133.3 15.2±21.2 0.002

Values are presented as mean±standard deviation. Wilcoxon signed rank test.

TOOLS
Similar articles